Department of Nuclear Medicine, Ludwig Maximilians-University of Munich
Munich, Bayern, Germany
Nathalie Albert is a senior physician and full professor for nuclear medicine at the LMU Munich, Germany. Her research focusses on PET imaging and theranostics of brain tumors. Dr. Albert leads national and international guidelines for the use of PET and radioligand therapies in brain tumor patients. She serves as chair of the Nuclear Medicine Committee of the EORTC Brain Tumour Group and is currently planning the first prospective randomized multicenter trial using radioligand therapy in Europe. Her work has been recognized by numerous research awards. In addition to her academic work, she is actively involved in promoting women and is the founder of FEMclub, a professional network for Female Excellence in Medicine.
